SAN FRANCISCO -- The adjuvant combination of pembrolizumab (Keytruda) and belzutifan (Welireg) significantly improved disease ...

With a new online resource, Eisai is offering patients and caregivers some direction to help navigate a kidney cancer ...

SAN FRANCISCO -- Dual antiangiogenic therapy for previously treated kidney cancer significantly improved progression-free survival (PFS) versus a single drug, a large randomized trial showed.

The treatment landscape for clear cell renal cell carcinoma (ccRCC) could be due for a shake-up following dual breakthroughs ...

Built on Insights from Patients and Caregivers, the New Website Curates Trusted Resources from Leading Organizations in Kidney Cancer NUTLEY, N.J., Feb. 26, 2026 /PRNewswire/ -- Eisai Inc. announced ...

According to Tang, this independence suggests that each biomarker provides unique prognostic information, making both valuable for understanding patient outcomes. Building on these findings, the ...

IceCure Medical (ICCM) announced the completion of its last patients’ five-year follow up evaluation in its ICESECRET ...

Earlier analyses demonstrated strong local tumor control, with nearly nine in 10 patients remaining free of recurrence at ...

Kidney cancer is not exclusively a disease of older patients. For many young adults, the diagnosis comes as a shock, often appearing without warning in those who otherwise feel healthy.

Eisai has a position in kidney cancer with Lenvima (lenvatinib), a kinase inhibitor that is approved for use in combination with MSD's cancer immunotherapy Keytruda (pembrolizumab) as a first-line ...

Dwyane Wade wants to block kidney cancer’s full-court press on your health. The retired NBA star recently opened up about his stage 1 kidney cancer diagnosis at age 41, admitting that he initially ...

The lead singer of the band 3 Doors Down shared Wednesday that he has stage 4 kidney cancer that has spread to his lung. In an Instagram video, Brad Arnold said he had been feeling sick for a few ...